A federal judge has refused to dismiss a class action suit accusing Pfizer Inc. of securities fraud for failing to disclose relevant data from a study it conducted about its arthritis drug Celebrex.
TheLegalIntelligencer.com
View this post on my blog: http://onlinefindlawyers.com/find-lawyers/securities-fraud-suit-against-pfizer-gets-green-light.html
没有评论:
发表评论